Skip to main content

Month: September 2025

Three New Football Fandoms Join the Tyson Custom Nugget Line-up

Tyson Foods brings fun to fans’ plates with new nugget collaborations with Denver Broncos, Green Bay Packers and Philadelphia Eagles SPRINGDALE, Ark., Sept. 03, 2025 (GLOBE NEWSWIRE) — Tyson® brand is inspiring fans with new culinary innovations that celebrate fandom and inspire a protein-packed tailgate this football season. Today, Tyson Foods is excited to announce three new chicken nugget offerings inspired by iconic football franchises: Denver Broncos, Green Bay Packers and Philadelphia Eagles.Perfect for any fan looking to show off their team spirit, the new chicken nuggets are made with all-white meat chicken and special touches that celebrate each team. The nuggets inspired by the Denver Broncos, Green Bay Packers and Philadelphia Eagles will be available in stadiums and regional retailers. “At Tyson Foods, we continue...

Continue reading

Greystone Logistics, Inc. Reports Revenues and Earnings for the Year Ended May 31, 2025

TULSA, Okla., Sept. 03, 2025 (GLOBE NEWSWIRE) — Greystone Logistics, (“Greystone Logistics” or the “Company”) (OTCQB:GLGI) the leading manufacturer of recycled plastic pallets providing sustainable logistics solutions, is pleased to announce its year-end earnings for the fiscal year ending May 31, 2025. The company has achieved a net income of $1,922,297 after preferred dividends of $428,713, with EBITDA of $10,008,828.22 on sales of $57,869,480.  Greystone Logistics is pleased to announce a successful year of significant debt reduction and balance sheet realignment. In 2025, we focused on strengthening our financial position, resulting in substantial progress and strategic investments that will support our growth. Warren Kruger CEO commented, “We reduced long term debt by $2,247,253, enhancing our financial stability and...

Continue reading

PharmAla Incorporates Australian Entity for Clinical Research

TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has incorporated PharmAla Biotech Australia Pty Ltd. (“PharmAla Australia”), a wholly-owned Australian subsidiary, for the purposes of conducting research and development activities in Australia. “As many know, Australia continues to be a thriving market for biotech development. We believe that our familiarity with the market – our relationships and our experience – will drive significant synergies,” said Nick Kadysh, Founding CEO, PharmAla Biotech. PharmAla Australia will receive a full and perpetual license to the company’s...

Continue reading

Critical Metals Corp NASDAQ CRML Reports Massive Mineralization Extension & Continues Resource Expansion These (3) 2024 Drilling Holes Intercepted Exceptional Rare Earth Elements Grading TREO Range 0.40% to 0.42% & HREO ∼26% Across our Flagship Core Asset Tanbreez in Greenland

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced for the first time three new assay results from the 2024 diamond drill hole program at the Fjord Deposit at the Tanbreez Rare Earth Project in Greenland. Highlights – 2024 New Diamond Drill Hole ResultsConsistent high-grade rare earth mineralization intersected in all four reported holes, with Total Rare Earth Oxide (TREO) grades between 0.40% and 0.42%. High proportion of heavy rare earth oxides (HREO) ~26% of TREO, reinforcing the deposit’s potential strategic value. Significant zirconium oxide (ZrO₂) grades of 1.57–1.58% across all holes. Gallium oxide (Ga₂O₃) assays between 93–99 ppm, providing a potential additional economic credit. All holes...

Continue reading

Grande Group Limited Drives Web3 Innovation as Exclusive Advisor to Drama3 Launch

Hong Kong, Sept. 03, 2025 (GLOBE NEWSWIRE) — GRANDE GROUP LIMITED (“GRAN” or the “Company”) (Nasdaq: GRAN), a Hong Kong-based financial services provider operating through its Hong Kong subsidiary, Grande Capital Limited, today announced its successful delivery of comprehensive real-world asset solutions and exclusive advisory services to Vividverse Capital Limited for the launch of Drama3. Drama3 is a Web3 infrastructure platform designed to transform short dramas and emerging intellectual properties into investable digital assets. The platform officially debuted today with its first flagship drama, Vanguard of Resistance, open for co-funding. Within six hours of its online launch, this drama achieved 30% of its total funding target. As the Company’s inaugural initiative into the Web3 space, the successful launch of Drama3 underscores...

Continue reading

Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

ATLANTA, Sept. 03, 2025 (GLOBE NEWSWIRE) —  Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announces it will participate in the H.C. Wainwright 27th Annual Global Investment Conference. The conference is being held on September 8 – 10, 2025 at the Lotte New York Palace Hotel. Greg Duncan, Chief Executive Officer will participate in a fireside chat with Sean Lee, VP of Equity Research at H.C. Wainwright on September 5, 2025.Time:  Available on-demand beginning at 7:00am ETWebcast Link: https://journey.ct.events/view/20673857-761f-4856-b863-2a5fbe671f60   A live webcast of the presentation can be accessed on the investor relations section of the Dogwood Therapeutics website. A replay of the...

Continue reading

Heliospace Hardware Successfully Completes Mission on the Moon

Deployable antennas and sensors successfully deploy and complete operations in support of geophysics experiment on the Moon. Berkeley, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Heliospace Corp. (OTC:HLEO), an aerospace company specializing in cutting-edge technologies that empower space exploration and innovation, today announced the successful completion of mission objectives for its deployable hardware and sensors on the Moon aboard the Firefly Aerospace Blue Ghost Mission 1. Heliospace provided critical mechanisms and a unique low frequency antenna as part of the Lunar Magnetotelluric Sounder (LMS) experiment on Blue Ghost Mission 1. Led by Southwest Research Institute, LMS is designed to study the interior of the Moon by measuring low frequency electromagnetic fields. Heliospace designed and built unique Remote Electrodes that...

Continue reading

Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor

SAN DIEGO and SUZHOU, China, Sept. 03, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, today announced the appointment of Dr. Axel Hoos as Executive Advisor. “Adagene is advancing the field of Immuno-Oncology with its pipeline of innovative antibodies centered around CTLA-4, a master-regulator of T-cell responses. This includes ADG116 to differentially engage CTLA-4 for greater T-reg depletion, and ADG126 to mask the CTLA-4 binder (ADG116) until it reaches the tumor microenvironment aiming for an enhanced efficacy and reduced toxicity profile. The design of these antibodies may allow a broader utility of CTLA-4 targeting in cancer immunotherapy” said Dr. Hoos. “CTLA-4 is a proven but notoriously difficult target. Most next-generation...

Continue reading

Round Table Pizza Slices Up Extra Cheesy Deal for National Cheese Pizza Day

A Deal That Can’t be Topped—$5 Personal Cheese Pizzas at Fan-Favorite Pizza Chain LOS ANGELES, Sept. 03, 2025 (GLOBE NEWSWIRE) — Round Table Pizza, a leading pizza franchise owned by FAT Brands Inc. known for its commitment to quality and authenticity, is giving another reason for its loyal fans to cheese big. Starting on National Cheese Pizza Day, Sept. 5, through Sept. 8, Royal Rewards Members can dig into a cheesy good deal – a $5 personal cheese pizza with any purchase valid at participating locations. “As our loyalty program grows, we continually look for ways to show our gratitude for our members’ commitment to the brand,” said Jillian Bowman, Brand Marketing Manager at Round Table Pizza. “Nothing beats a classic cheese pizza—especially one made with our gold-standard ingredients, including our signature three-cheese blend....

Continue reading

PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow

New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in epigenetics tools, has joined the PacBio Compatible program. The partnership brings EpiCypher’s CUTANA® Hia5 enzyme to market for use with Fiber-seq assays on PacBio HiFi sequencing systems, giving researchers a new way to see chromatin biology at single-molecule resolution. Fiber-seq (single-molecule chromatin fiber sequencing) is an advanced multi-omic whole genome sequencing (WGS) assay that simultaneously measures chromatin accessibility, DNA methylation,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.